BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 33235459)

  • 1. Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer.
    Li J; Qin Z; Li Y; Huang B; Xiao Q; Chen P; Luo Y; Zheng W; Zhang T; Zhang Z
    Adv Sci (Weinh); 2024 Apr; ():e2310208. PubMed ID: 38582508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells.
    Zhang Q; Chen X; Hu Y; Zhou T; Du M; Xu R; Chen Y; Tang P; Chen Z; Li J
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Dp-1 knockdown downregulates thymidine kinase 1 expression to protect against proliferation and epithelial-mesenchymal transition in cervical cancer.
    Wu M; Ye M
    Funct Integr Genomics; 2023 Sep; 23(4):301. PubMed ID: 37715794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma.
    Yang L; Fan Q; Wang J; Yang X; Yuan J; Li Y; Sun X; Wang Y
    Cell Death Discov; 2023 Jun; 9(1):185. PubMed ID: 37344459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel prognostic circRNA biomarkers in circRNA-miRNA-mRNA regulatory network in gastric cancer and immune infiltration analysis.
    Yan J; Ye G; Jin Y; Miao M; Li Q; Zhou H
    BMC Genomics; 2023 Jun; 24(1):323. PubMed ID: 37312060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSX1-expression during the different phases in healthy human endometrium.
    Eppich S; Kuhn C; Schmoeckel E; Mayr D; Mahner S; Jeschke U; Gallwas J; Heidegger HH
    Arch Gynecol Obstet; 2023 Jul; 308(1):273-279. PubMed ID: 37101223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma.
    Lv M; Chen P; Bai M; Huang Y; Li L; Feng Y; Liao H; Zheng W; Chen X; Zhang Z
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer.
    Gui Z; Ying X; Liu C
    J Oncol; 2022; 2022():4271409. PubMed ID: 36245981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps.
    Isik Z; Leblebici A; Demir Karaman E; Karaca C; Ellidokuz H; Koc A; Ellidokuz EB; Basbinar Y
    PLoS One; 2022; 17(4):e0267973. PubMed ID: 35486660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review of the roles of muscle segment homeobox transcription factor family in cancer.
    Liu C; Huang M; Han C; Li H; Wang J; Huang Y; Chen Y; Zhu J; Fu G; Yu H; Lei Z; Chu X
    Ann Transl Med; 2021 May; 9(9):810. PubMed ID: 34268423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
    Dore M; Filoche S; Danielson K; Henry C
    Gynecol Oncol Rep; 2021 May; 36():100732. PubMed ID: 33718563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
    Yang L; Cui Y; Sun X; Wang Y
    Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
    Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
    PeerJ; 2020; 8():e9100. PubMed ID: 32377460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
    Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
    PeerJ; 2020; 8():e10142. PubMed ID: 33150073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer.
    Yang L; Cui Y; Huang T; Sun X; Wang Y
    Onco Targets Ther; 2020; 13():11669-11688. PubMed ID: 33235459
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.